Literature DB >> 18973141

Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract.

Nicola Arrighi1, Serena Bodei, Danilo Zani, Claudio Simeone, Chiara Fiorentini, Cristina Missale, Giulio Milanese, Marco Dellabella, Giovanni Muzzonigro, Sergio Cosciani Cunico, PierFranco Spano, Sandra Sigala.   

Abstract

AIMS: Evidence indicates that dopamine (DA) and DA receptors play a role in the central nervous system (CNS) control of micturition; however, while the central DAergic role in the micturition physiology has been extensively investigated, the expression and the function of DA receptors in the urinary tract are still under investigation. Here, we studied the distribution of DA receptor subtypes in different parts of the human male urinary tract.
METHODS: Fragments were collected from 34 men. The mRNAs encoding DA receptors were assessed by RT-PCR, followed by densitometric analysis. Adenylyl cyclase (AC) activity was evaluated using a commercially available RIA kit. Statistical analysis was carried out using one-way ANOVA, with the Bonferroni's post hoc test.
RESULTS: Results obtained indicated that RT-PCR products of D(1), D(4), and D(5) subtypes were obtained in each part studied, while no signal was observed for the D(2) and D(3) receptor subtypes. The pharmacological characterization demonstrated that the expressed DA receptors were linked to AC.
CONCLUSIONS: DA receptors were expressed throughout the human male urinary tract, from the ureter to the prostatic urethra. In particular, we observed a distinctive DA receptor subtype distribution, with evidence of the presence of mRNA encoding both subtypes of the D(1)-like DA receptor family (D(1) and D(5)), while the D(4) receptors were the only expressed subtype of the D(2)-like family. These results suggested that DAergic drugs used for the treatment of a number of diseases may influence the micturition physiology not only in the CNS, but at the peripheral level as well. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18973141     DOI: 10.1002/nau.20652

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  2 in total

1.  Should we be cautious on the use of commercially available antibodies to dopamine receptors?

Authors:  Serena Bodei; Nicola Arrighi; PierFranco Spano; Sandra Sigala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-19       Impact factor: 3.000

2.  Deciphering Spinal Endogenous Dopaminergic Mechanisms That Modulate Micturition Reflexes in Rats with Spinal Cord Injury.

Authors:  Shaoping Hou; Jaclyn H DeFinis; Stephanie L Daugherty; Chuanxi Tang; Jeremy Weinberger; William C de Groat
Journal:  eNeuro       Date:  2021-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.